Cibus, Inc.
General ticker "CBUS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $44.0M (TTM average)
Cibus, Inc. does not follow the US Stock Market performance with the rate: -0.4%.
Estimated limits based on current volatility of 8.7%: low 2.69$, high 3.21$
Factors to consider:
- Total employees count: 183 as of 2023
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.04$, 4.53$]
- 2025-12-31 to 2026-12-31 estimated range: [0.75$, 3.14$]
Financial Metrics affecting the CBUS estimates:
- Positive: with PPE of -0.9 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -91.82 <= 0.06
- Positive: 19.59 < Shareholder equity ratio, % of 26.33 <= 42.74
- Positive: Return on assets ratio (scaled to [-100,100]) of 44.68 > 6.13
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term CBUS quotes
Long-term CBUS plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.16MM | $1.82MM | $4.26MM |
| Operating Expenses | $22.53MM | $320.70MM | $262.66MM |
| Operating Income | $-22.37MM | $-318.88MM | $-258.40MM |
| Non-Operating Income | $5.48MM | $-18.76MM | $-24.29MM |
| Interest Expense | $0.09MM | $18.89MM | $34.19MM |
| R&D Expense | $11.55MM | $42.37MM | $50.43MM |
| Income(Loss) | $-16.89MM | $-337.64MM | $-282.68MM |
| Taxes | $0.00MM | $-0.00MM | $-0.03MM |
| Profit(Loss)* | $-16.89MM | $-267.63MM | $-251.39MM |
| Stockholders Equity | $7.23MM | $293.47MM | $92.16MM |
| Assets | $22.42MM | $544.41MM | $350.07MM |
| Operating Cash Flow | $-19.36MM | $-46.21MM | $-58.04MM |
| Capital expenditure | $1.52MM | $4.32MM | $0.81MM |
| Investing Cash Flow | $-1.52MM | $55.06MM | $-0.81MM |
| Financing Cash Flow | $9.99MM | $20.32MM | $40.60MM |
| Earnings Per Share** | $-0.03 | $-25.95 | $-10.83 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.